Sepsis Clinical Trials in Philadelphia, Pennsylvania

6 studies are recruiting for sepsis in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

    This study will enroll adults aged 18 to 80 years diagnosed with sepsis due to a suspected or confirmed bacterial infection, within 7 days of being admitted to the hospital, and who have also developed acute kidney injury within 72 hours of the onset of sepsis. Eligible participants will be randoml…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Research Site, Philadelphia, Pennsylvania
    Locations
    74 in total
    Run by
    AstraZeneca
  2. Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention

    The goal of this clinical trial is to determine if vancomycin dosing in children with sepsis can be improved by using updated, personalized dosing models that account for new markers of an individual's kidney function. Vancomycin is prescribed based on the known information of how the body breaks t…

    Stage
    Phase 1
    Ages
    0 to 17
    Site
    Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    Run by
    Children's Hospital of Philadelphia
  3. Safe and Explainable AI

    While current AI technology is suitable for automating some repetitive clinical tasks, technical challenges remain in solving critical and gainful problems in the domains of patient and disease management. The proposed research seeks to address issues in medical AI, such as integrating medical know…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
    Run by
    Abramson Cancer Center at Penn Medicine
  4. The APS Phenotyping Study

    The goal of the observational APS phenotyping study is to better understand risk factors, potential biomarkers, length and severity of illness, and recovery for adults with ARDS, pneumonia, and/ or sepsis. This study will also generate a biobank of specimens collected from these patients that will …

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Pennsylvania, Philadelphia, Pennsylvania
    Locations
    20 in total
    Run by
    Vanderbilt University Medical Center
  5. External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients

    To demonstrate that external drainage of thoracic duct lymph during sepsis results in a reduction in circulating pro-inflammatory cytokines. To demonstrate safety and feasibility of early thoracic duct cannulation and external lymph drainage for up to 7 days in adult surgical intensive care patient…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
    Run by
    University of Pennsylvania
  6. Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis

    The goal of this quasi-experimental interventional study is to determine the effectiveness of a multifaceted stewardship intervention in reducing overall vancomycin use in five tertiary care Pediatric Intensive Care Units (PICU). There are two groups of subjects in this study: PICU clinicians/sepsi…

    Stage
    Not phased
    Ages
    Any age
    Site
    Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    Locations
    4 in total
    Run by
    Children's Hospital of Philadelphia

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.